FDA Inspection
Fresenius Kabi Oncology LimitedFresenius Kabi Oncology Limited – FDA Inspection, May 24, 2017
Record Details
This FDA Inspection record concerns Fresenius Kabi Oncology Limited, with an inspection on May 24, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d569f1f7-caae-429c-9a4e-d98d64f869b0
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1013712
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Fresenius Kabi Oncology Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 3, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 18, 2013 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi Oncology Limited
- FDA Inspection 924144 - 2015-03-03
- FDA Inspection 815170 - 2013-01-18
- FDA Inspection 630128 - 2009-11-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.